Quantcast
Last updated on April 21, 2014 at 7:52 EDT

Latest Ironwood Pharmaceuticals Inc. Stories

2013-12-17 08:26:12

NEW YORK, December 17, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Insys Therapeutics, Inc. (NASDAQ: INSY), Integra Lifesciences Holdings Corporation (NASDAQ: IART), Bio-Reference Laboratories, Inc. (NASDAQ: BRLI), Raptor Pharmaceutical Corp. (NASDAQ: RPTP), and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD). Today's readers may access these reports...

2013-10-28 08:26:17

NEW YORK, October 28, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Alere Inc. (NYSE: ALR), Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), Magellan Health Services Inc. (NASDAQ: MGLN), Foundation Medicine, Inc. (NASDAQ: FMI), and InterMune Inc. (NASDAQ: ITMN). Today's readers may access these reports free of charge - including full price targets,...

2013-03-07 08:29:37

NEW YORK, March 7, 2013 /PRNewswire/ -- Today, Investors Alliance announced new research reports highlighting Pfizer Inc. (NYSE: PFE), Theravance Inc (NASDAQ: THRX), ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS), Infinity Pharmaceuticals Inc. (NASDAQ: INFI) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Pfizer Inc. Research...

2013-01-04 12:22:52

CHICAGO, Jan. 4, 2013 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include ADP (Nasdaq:ADP), Ironwood Pharmaceuticals, Inc. (Nasdaq:IRWD), Forest Laboratories, Inc. (NYSE:FRX), Valeant Pharmaceuticals International, Inc. (NYSE:VRX) and Novo Nordisk (NYSE:NVO). (Logo:...

2012-11-28 12:26:33

BARCELONA, Spain and CAMBRIDGE, Massachusetts, November 28, 2012 /PRNewswire/ -- - Constella(R) (linaclotide) is the first and only medicine approved by the European Commission for the symptomatic treatment of moderate to severe IBS-C in adults, that improves abdominal pain/discomfort, bloating and constipation - First launches in Europe are expected in the first half of 2013 - IBS-C is a functional gastrointestinal disorder...

2012-10-31 15:25:29

SAN DIEGO, Oct. 31, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the signing of an amendment to the lease with Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) at its 301 Binney Street facility in Cambridge, Massachusetts. As a result of this lease extension and phased expansion totaling approximately 93,000 square feet, Ironwood's occupancy in the five-story, state-of-the-art facility will increase to approximately 303,000 square feet. The term of the...

2012-05-11 02:23:36

MENLO PARK, Calif., May 11, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it has received a $1 million milestone payment from Ironwood Pharmaceuticals, Inc. following the development and delivery of a prototype formulation of an Ironwood development candidate meeting pre-specified attributes under its Research Collaboration and License Agreement to license Acuform® technology to Ironwood signed in July 2011. Under the terms of the agreement, Depomed licensed to...

2011-12-13 07:00:00

NEW YORK, Dec. 13, 2011 /PRNewswire/ -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYPD, SGYPU), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has filed a lawsuit in New York State Supreme Court against Ironwood Pharmaceuticals, Inc. (Nasdaq:IRWD) and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie. The lawsuit alleges that after European patent 1,379,224 was granted to Synergy but prior to issuance, Ironwood...

2011-09-29 05:55:00

BARCELONA, Spain, September 29, 2011 /PRNewswire/ -- - Linaclotide has demonstrated statistically significant improvement in abdominal pain/discomfort and global relief of IBS-C symptoms in Phase III clinical trials [1,2] - IBS-C is a debilitating disease associated with reduced quality of life and considerable socio-economic and psychological consequences [3,4] Almirall, S.A. (ALM.MC) announced today that it has submitted a Marketing Authorisation Application...

2010-02-16 15:05:00

SAN DIEGO, Feb. 16 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the signing of an amendment to its lease with Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) at its 301 Binney Street laboratory research facility in Cambridge, Massachusetts. Ironwood has agreed to lease an additional 50,000 square feet of laboratory and office space contiguous to its existing premises located in the heart of the Kendall Square life science research super-cluster. As a result...